Cardiac Toxicity of 5-Fluorouracil: A Study on 1083 Patients

作者：Roberto Labianca, Gianni Beretta, Maurizia Clerici, Paolo Fraschini, Gino Luporini · 发表于：Tumori Journal · 年份：1982 · DOI：10.1177/030089168206800609 · 被引用次数：287 · 研究领域：Chemotherapy-induced cardiotoxicity and mitigation、Colorectal Cancer Treatments and Studies、Cancer Treatment and Pharmacology

The possible onset of cardiotoxic manifestations during chemotherapy with 5-fluorouracil (5-FU) was evaluated in 1083 patients treated with the drug for various kinds of neoplasm. We recognized 17 cases of 5-FU cardiopathy (usually anginous crises but also myocardial infarction). The comprehensive incidence was 1.6%, with a significantly greater risk (4.5% vs 1.1%) for patients with a positive anamnesis of previous cardiopathy. On the contrary, age and combination with other antiblastic drugs had no affect on the appearance of cardiopathy. We conclude that 5-FU cardiopathy, although rare, has to be taken into account in oncologic practice, chiefly in those patients already affected with cardiac diseases.